Form 4: Fennec Pharmaceuticals CFO Sells Shares
Insider Transaction (Form 4)
Robert Andrade, CHIEF FINANCIAL OFFICER of Fennec Pharmaceuticals Inc., sold 75,000 shares of common stock on August 27, 2026 for $11.78 per share.
Summary
- Open-market sale: disposed of 75,000 Common shares at $11.78 ($883,500) on August 27, 2026; holds 217,675 after (Direct).
- Option exercise/conversion: acquired 21,928 Common shares at $5.10 ($111,833) on August 28, 2026; holds 239,603 after (Direct).
- Option exercise/conversion: disposed of 21,928 Stock Options on August 28, 2026; holds 779,330 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $883,500 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Robert Andrade — Officer (CHIEF FINANCIAL OFFICER)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Open-market sale | Common shares | 75,000 | $12 | $883.5K | 217,675 |
| 2026-08-28 | Option exercise/conversion | Common shares | 21,928 | $5 | $111.8K | 239,603 |
| 2026-08-28 | Option exercise/conversion | Stock Options | 21,928 | — | — | 779,330 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Open-market sale (75,000 shares) |
| 2026-08-28 | Option exercise/conversion (21,928 shares) |
| 2026-08-28 | Option exercise/conversion (21,928 shares) |
Keywords
insider transaction, Form 4, FENC, FENNEC PHARMACEUTICALS INC., bearish, Robert Andrade
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.